Discover what Emgality can do for patients with chronic migraine1
For your patients with ≥15 headache days per month,1
Meet a patient with chronic migrainea
- 15 or more unpredictable headache days per month
- Has tried therapeutic doses of 2 standard-of care generic preventives
- May now be only relying on her acute treatments
SELECT IMPORTANT SAFETY INFORMATION
Emgality is contraindicated in patients with serious hypersensitivity to galcanezumab-gnlm or to any of the excipients.